Bank of Montreal’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.33M Buy
180,000
+109,000
+154% +$2.85M ﹤0.01% 1427
2026
Q1
$1.99M Buy
71,000
+54,000
+318% +$1.44M ﹤0.01% 1670
2025
Q4
$423K Buy
+17,000
New +$429K ﹤0.01% 2391
2022
Q1
– Sell
-150,000
Closed -$8.82M – 4258
2021
Q4
$8.82M Buy
+150,000
New +$7.43M ﹤0.01% 1005
2021
Q1
– Sell
-105,700
Closed -$3.99M – 5285
2020
Q4
$3.99M Buy
+105,700
New +$3.88M ﹤0.01% 1513
2020
Q3
– Sell
-228,296
Closed -$7.25M – 4892
2020
Q2
$7.25M Buy
+228,296
New +$7.76M 0.01% 1000
2020
Q1
– Sell
-147,560
Closed -$5.49M – 4553
2019
Q4
$5.49M Buy
+147,560
New +$5.26M ﹤0.01% 1295
2019
Q3
– Sell
-222,394
Closed -$9.14M – 4927
2019
Q2
$9.14M Buy
+222,394
New +$8.83M 0.01% 936
2019
Q1
– Sell
-30,724
Closed -$1.27M – 4634
2018
Q4
$1.27M Buy
+30,724
New +$1.28M ﹤0.01% 1770
2017
Q2
– Sell
-369
Closed -$12K – 4251
2017
Q1
$12K Hold
369
– – ﹤0.01% 3504
2016
Q4
$11K Buy
+369
New +$11.3K ﹤0.01% 3567
2016
Q3
– Sell
-369
Closed -$12K – 4155
2016
Q2
$12K Sell
369
-685
-65% -$21.9K ﹤0.01% 3543
2016
Q1
$30K Sell
1,054
-38,998
-97% -$1.11M ﹤0.01% 3235
2015
Q4
$1.23M Buy
+40,052
New +$1.26M ﹤0.01% 1630
2014
Q2
– Sell
-355,936
Closed -$10.8M – 4777
2014
Q1
$10.8M Buy
+355,936
New +$10.6M 0.01% 632

Other funds holding PFE

Bank of Montreal's PFE Position: Q2 2026 in Review

Bank of Montreal increased its Pfizer (PFE) stake by 6.5% in Q2 2026, buying an estimated $13.1M and bringing the position to 8,168,120 shares worth $197M. The position accounts for 0.06% of the portfolio, ranked #239.

Bank of Montreal first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $971M in Q3 2018. 2,840 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bank of Montreal held 8,168,120 shares of Pfizer worth $197M as of Q2 2026.
  • Bank of Montreal bought 500,715 Pfizer shares in Q2 2026, an estimated $13.1M.
  • Pfizer made up 0.06% of Bank of Montreal's portfolio in Q2 2026, its #239 holding.
  • Bank of Montreal first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Pfizer position peaked at $971M in Q3 2018.
  • 2,840 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.